Medivir AB (publ)
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Medivir AB (publ) generated cash of -$101,820,000, which is less than the previous year. Cash used in financing activities reached the amount of -$1,535,000 last year. Net change in cash is therefore -$103,733,000.
Cash Flow
| 2013 | 43.04M | 110.97M | -48.61M |
|---|---|---|---|
| 2014 | 1.01B | -17.66M | -1K |
| 2015 | 307.38M | -15.04M | -611.57M |
| 2016 | -182.28M | 803.19M | 0 |
| 2017 | -358.48M | -13.54M | -858.64M |
| 2018 | -318.63M | -6.83M | 143.79M |
| 2019 | -148.25M | 4.49M | -6.65M |
| 2020 | -58.05M | 5.36M | -12.11M |
| 2021 | -48.73M | 0 | 199.4M |
| 2022 | -101.82M | -382K | -1.53M |
0GP7.L Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 221.16M | 70.00M | 134.50M | 286.28M | 467.78M | 1.69B | 1.07B | 1.39B | 402.22M | 296.72M |
Operating activities | ||||||||||
Net income | -88.76M | -62.57M | -42.62M | -123.33M | -350.31M | -360.21M | 282.85M | 75.09M | 1.13B | -21.33M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 2.57M | 2.59M | 4.43M | 7.08M | 26.30M | 29.96M | 33.46M | 34.12M | 33.19M | 32.93M |
Stock-based compensation expense | 0 | 0 | 0 | 0 | 0 | 0 | 1.24M | 0 | 0 | 4M |
| Deferred income tax benefit | 0 | 0 | 0 | 0 | 0 | 0 | 1.24M | 0 | 0 | 4M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -860K | 4.84M | 8.58M | 5.00M | 0 | 0 | 0 | 0 | 0 | -25.26M |
Inventories | 0 | 0 | 0 | 0 | 0 | 432K | -6.03M | 4.91M | 374K | -19.25M |
Accounts payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by operating activities | -101.82M | -48.73M | -58.05M | -148.25M | -318.63M | -358.48M | -182.28M | 307.38M | 1.01B | 43.04M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -382K | 0 | -2.68M | -1.43M | -6.83M | -13.54M | -106.32M | -20.08M | -20.16M | -3.59M |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 908.34M | 5.04M | 2.50M | 0 |
Cash generated by investing activities | -382K | 0 | 5.36M | 4.49M | -6.83M | -13.54M | 803.19M | -15.04M | -17.66M | 110.97M |
Financing activities | ||||||||||
Common Stock Issued | 404K | 223.51M | 595K | 0 | 155.07M | 494K | 0 | 0 | 0 | 0 |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | -857.47M | 0 | -611.57M | 0 | 0 |
Repayments of term debt | 0 | -2.47M | -12.71M | 0 | 0 | 0 | 0 | 0 | 0 | -88.61M |
Cash used in financing activities | -1.53M | 199.4M | -12.11M | -6.65M | 143.79M | -858.64M | 0 | -611.57M | -1K | -48.61M |
Net Change In Cash | -103.73M | 151.16M | -64.50M | -151.77M | -181.49M | -1.23B | 620.53M | -317.67M | 993.40M | 105.49M |
Cash at end of period | 117.43M | 221.16M | 70.00M | 134.50M | 286.28M | 467.78M | 1.69B | 1.07B | 1.39B | 402.22M |
| Data source |